Brain natriuretic peptide: Disease marker or more in cardiovascular medicine?

Authors
Citation
Sa. Doggrell, Brain natriuretic peptide: Disease marker or more in cardiovascular medicine?, DRUGS TODAY, 37(7), 2001, pp. 463-476
Citations number
90
Categorie Soggetti
Pharmacology
Journal title
DRUGS OF TODAY
ISSN journal
00257656 → ACNP
Volume
37
Issue
7
Year of publication
2001
Pages
463 - 476
Database
ISI
SICI code
0025-7656(200107)37:7<463:BNPDMO>2.0.ZU;2-L
Abstract
Brain natriuretic peptide (BNP) is predominantly a cardiac ventricular horm one that promotes natriuresis and diuresis, inhibits the renin-anglotensin- aldosterone axis, and is a vasodilator. Plasma BNP levels are raised in ess ential hypertension, and more so in left ventricular (LV) hypertrophy and h eart failure. Plasma BNP levels are also elevated in ischemic heart disease . Attempts have been made to use plasma BNP levels as a marker of LV dysfun ction, but these have shown that plasma BNP levels are probably not sensiti ve enough to replace echocardiography in the diagnosis of LV dysfunction. P ericardial BNP or N-BNP may be more suitable markers of LV dysfunction. Pla sma BNP levels are also elevated in right ventricular dysfunction, pregnanc y-induced hypertension, aortic stenosis, age, subarachnoid hemorrhage, card iac allograft rejection and cavopulmonary connection, and BNP may have an i mportant pathophysiological role in some or all of these conditions. Clinic al trials have demonstrated the natriuretic, diuretic and vasodilator effec ts, as well as inhibitory effects on renin and aldosterone of infused synth etic human BNP (nesiritide) in healthy humans. BNP infusion improves LV fun ction in patients with congestive heart failure via a vasodilating and a pr ominent natriuretic effect. BNP infusion is useful for the treatment of dec ompensated congestive heart failure requiring hospitalization. The clinical potential of BNP is limited as it is a peptide and requires infusion. Drug s that modify the effects of BNP are furthering our understanding of the pa thophysiological role and clinical potential of BNP. Increasing the effects of BNP may be a useful therapeutic approach in heart failure involving LV dysfunction. The levels of plasma BNP are increased by blockers, cardiac gl ycosides and vasopeptidase inhibitors, and this may contribute to the usefu lness of these agents in heart failure. (C) 2001 Prous Science. All rights reserved.